RSS

Lucentis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

A co-development agreement has been formed by Xbrane Biopharma and STADA Arzeneimittel for the development of Xlucane — a biosimilar to Lucentis (ranibizumab), which is mainly used for the treatment of wet age-related macular degeneration (AMD). Read more

News

The US FDA has approved Genetech’s Lucentis (ranibizumab injection) 0.3 mg prefilled syringe as a new administration method for the treatment of all forms of diabetic retinopathy (DR) in patients with diabetic macular oedema Read more

News

The controversy surrounding Avastin and Lucentis has reared its head again as it has been revealed that health chiefs may face a legal fight if they go ahead with plans to offer the cheaper drug (Avastin) to patients with wet AMD on the NHS Read more

News